AstraZeneca rejected close to £80mn in state support for cancelled Speke factory 0 03.02.2025 08:00 Financial Times UK’s most valuable listed company raised NHS rejection of its new breast cancer drug and the drug pricing mechanism during negotiations Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
